
INTERNATIONAL
JOURNAL
OF
DIAGNOSTICS
AND
RESEARCH
Copyright @ : - Dr.Subhash Waghe Inter. J.Digno. and Research IJDRMSID0126 |ISSN :2584-2757
Introduction :
Obesity and diabetes mellitus, particularly type 2
diabetes mellitus (T2DM), represent a dual
epidemic with profound global health and
socioeconomic consequences. According to the
International Diabetes Federation, approximately
537 million adults were living with diabetes in
2021, a figure projected to reach 783 million by
2045.
[1]
Concurrently, the World Health
Organisation reports that approximately 1.9 billion
adults are overweight, of whom over 650 million
are clinically obese.
[2]
These conditions are
pathophysiologically interconnected, sharing
common aetiological pathways including insulin
resistance, chronic low-grade inflammation,
oxidative stress, and dysregulation of adipokines.
[3]
Contemporary pharmacological management, while
effective, is associated with adverse effects, drug
resistance, economic burden, and poor long-term
adherence, necessitating complementary and
alternative therapeutic strategies. Dietary
intervention, recognised as a cornerstone of
metabolic disease management, has increasingly
incorporated principles from traditional systems of
medicine.
[4]
Ayurveda, the ancient Indian system of medicine,
has long advocated the therapeutic use of dietary
vegetables (Shaka) as both food and medicine. The
Sushruta Samhita (circa 600 BCE), one of the
foundational texts of Ayurvedic surgery and
pharmacology, enumerates a dedicated group of
vegetables in its chapter "Shaka Varga" within the
Sutra Sthana. These vegetables, collectively termed
Sushrutokta Shak Varga, are characterised by
specific Ayurvedic pharmacological properties
(Rasa, Guna, Virya, Vipaka) and clinical
indications relevant to the Ayurvedic constructs of
Sthaulya (obesity) and Prameha (a spectrum of
urinary and metabolic disorders that broadly
encompasses diabetes mellitus).
[5]
Despite the long-standing empirical use of these
vegetables in Ayurvedic clinical practice, a
systematic, evidence-based critical evaluation—
anchored in the principles of modern nutritional
science such as Glycemic Index (GI), Glycemic
Load (GL), macronutrient profiling, and
phytochemical analysis—is conspicuously absent
from the existing literature. The Glycemic Index,
introduced by Jenkins et al. in 1981,
[6]
quantifies
the postprandial blood glucose response relative to
a reference food, and has emerged as a powerful
tool in the nutritional management of T2DM and
obesity. Foods with low GI values (<55) are
associated with improved insulin sensitivity,
reduced postprandial hyperglycaemia, enhanced
satiety, and favourable modulation of lipid
profiles.
[7][8]
This research article aims to bridge the epistemic
gap between classical Ayurvedic pharmacognosy
and contemporary nutritional science by
undertaking a comprehensive critical evaluation of
Sushrutokta Shak Varga, correlating Ayurvedic
therapeutic rationale with modern evidence
pertaining to GI, GL, nutritional value,
phytoconstituents, and molecular mechanisms of
action in the context of obesity and diabetes
mellitus.
Material & Method:
Study Design :
This study adopts a narrative critical review design,